Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system
- 10 July 2004
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 103 (1) , 1-20
- https://doi.org/10.1016/j.pharmthera.2004.05.001
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in miceLife Sciences, 1997
- Attention deficit disorder and hyperactivity - changes in hypothalamic function in hyperactive children: a new modelMedical Hypotheses, 1997
- Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in miceLife Sciences, 1995
- Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptomsSchizophrenia Research, 1995
- The behavioral effects of serotonin synthesis inhibition and quisqualic acid induced lesions of the nucleus basalis magnocellularis in ratsGeneral Pharmacology: The Vascular System, 1993
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulantsBehavioral and Neural Biology, 1992
- Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slicesNeurochemistry International, 1991
- Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluidArchives of Gerontology and Geriatrics, 1991
- Different forms of post-training memory processingBehavioral and Neural Biology, 1989